UK Regulator Sees No Heart Inflammation Concerns from Pfizer Vaccine
There are no new safety concerns around the Pfizer COVID-19 vaccine and heart inflammation based on the rollout of the shot in Britain, the UK MHRA medicine regulator said on Wednesday, after cases of the condition were reported in Israel.
“The MHRA is aware of the reports of myocarditis under investigation in Israel. Based on our experience and safety monitoring in the UK, there is currently no new safety concerns raised regarding myocarditis,” a MHRA spokeswoman said.
The comment echoed the U.S. Centers for Disease Control and Prevention (CDC) which said it had not seen a link between the shot and heart inflammation.
To Read The Full Story
Are you already a subscriber?
Click "Sign In" to log in!
Become a Web Subscriber
Click “Subscribe” below to begin the process of becoming a new subscriber.
Become a Print + Web Subscriber
Click “Subscribe” below to begin the process of becoming a new subscriber.
Renew Print + Web Subscription
Click “Renew Subscription” below to begin the process of renewing your subscription.
